AG
MRNA icon

Algert Global’s Moderna MRNA Stock Holding History

Algert Global’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.2M Buy
274,820
+37,402
+16% +$1.94M 0.23% 97
2026
Q1 		$12.1M Buy
237,418
+53,058
+29% +$2.48M 0.18% 157
2025
Q4 		$5.44M Buy
184,360
+31,030
+20% +$843K 0.08% 401
2025
Q3 		$3.96M Buy
153,330
+61,620
+67% +$1.72M 0.07% 477
2025
Q2 		$2.53M Buy
+91,710
New +$2.42M 0.05% 562

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Algert Global's MRNA Position: Q2 2026 in Review

Algert Global increased its Moderna (MRNA) stake by 16% in Q2 2026, buying an estimated $1.94M and bringing the position to 274,820 shares worth $19.2M. The position accounts for 0.23% of the portfolio, ranked #97.

Algert Global first reported a position in MRNA in Q2 2025 and has held it in 5 quarters since. 780 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Algert Global held 274,820 shares of Moderna worth $19.2M as of Q2 2026.
  • Algert Global bought 37,402 Moderna shares in Q2 2026, an estimated $1.94M.
  • Moderna made up 0.23% of Algert Global's portfolio in Q2 2026, its #97 holding.
  • Algert Global first reported a position in Moderna in Q2 2025 and has held it in 5 quarters since.
  • 780 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.